全文获取类型
收费全文 | 102432篇 |
免费 | 8725篇 |
国内免费 | 4461篇 |
专业分类
耳鼻咽喉 | 1123篇 |
儿科学 | 1677篇 |
妇产科学 | 2518篇 |
基础医学 | 11325篇 |
口腔科学 | 1841篇 |
临床医学 | 12097篇 |
内科学 | 16445篇 |
皮肤病学 | 1632篇 |
神经病学 | 5328篇 |
特种医学 | 4072篇 |
外国民族医学 | 8篇 |
外科学 | 11702篇 |
综合类 | 13924篇 |
现状与发展 | 20篇 |
一般理论 | 11篇 |
预防医学 | 7173篇 |
眼科学 | 2230篇 |
药学 | 9633篇 |
70篇 | |
中国医学 | 4678篇 |
肿瘤学 | 8111篇 |
出版年
2024年 | 222篇 |
2023年 | 1005篇 |
2022年 | 2601篇 |
2021年 | 3835篇 |
2020年 | 2690篇 |
2019年 | 2612篇 |
2018年 | 3037篇 |
2017年 | 2643篇 |
2016年 | 2562篇 |
2015年 | 3858篇 |
2014年 | 4932篇 |
2013年 | 5567篇 |
2012年 | 8009篇 |
2011年 | 8201篇 |
2010年 | 5843篇 |
2009年 | 5040篇 |
2008年 | 6096篇 |
2007年 | 6121篇 |
2006年 | 5775篇 |
2005年 | 5086篇 |
2004年 | 4568篇 |
2003年 | 4403篇 |
2002年 | 3884篇 |
2001年 | 2996篇 |
2000年 | 2393篇 |
1999年 | 1828篇 |
1998年 | 843篇 |
1997年 | 771篇 |
1996年 | 651篇 |
1995年 | 565篇 |
1994年 | 495篇 |
1993年 | 320篇 |
1992年 | 789篇 |
1991年 | 648篇 |
1990年 | 571篇 |
1989年 | 531篇 |
1988年 | 454篇 |
1987年 | 443篇 |
1986年 | 367篇 |
1985年 | 299篇 |
1984年 | 232篇 |
1983年 | 191篇 |
1982年 | 114篇 |
1981年 | 123篇 |
1980年 | 100篇 |
1979年 | 205篇 |
1978年 | 161篇 |
1977年 | 103篇 |
1976年 | 110篇 |
1975年 | 102篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
p53基因(今又生(R))联合支气管动脉化疗治疗肺癌15例近期疗效观察 总被引:1,自引:0,他引:1
目的探讨瘤内注射或经支气管动脉灌注p53基因联合支气管动脉灌注化疗(BAI)治疗肺癌的安全性、疗效和给药途径.方法经病理证实的15例肺癌,首先在CT引导下经皮穿刺瘤内注射或经支气管动脉灌注p53基因(今又生(R)),2~5天后,行BAI灌注化疗药物;然后根据病情变化再次进行基因治疗和/或BAI.治疗后常规使用螺旋CT定期复查,评价治疗效果.结果全部15例患者均完成上述治疗,并接受随访2~11个月.有效率(CR PR)46.7%(7/15),1例肺部肿块消失,6例肺部肿块缩小,3例纵隔淋巴结缩小,1例胸水减少,仅1例观察到肿瘤长大,14例临床症状有不同程度缓解93.3%(14/15).p53治疗后6例出现发热(38℃~40℃),未观察到基因药物的其它严重副作用,无严重操作有关并发症出现.结论本研究结果初步显示,作为肿瘤综合治疗的一部分,p53基因治疗与BAI联合应用,是一种治疗肺癌安全、有效的方法,提高了BAI的治疗效果.经皮瘤内注射p53是否为一种较好的给药途径值得进一步探讨. 相似文献
102.
目的观察初诊T2DM短期胰岛素强化治疗的疗效。方法对40例初诊T2DM患者采用三餐前皮下注射短效胰岛素和睡前注射中效胰岛素2wk,并检测治疗2wk前后FPG、PPG、GHbA1C及血脂等值进行比较。结果两组治疗后FPG、PPG、GHbA1C及血脂各值均显著低于治疗前p〈0.05(x^2=4.940—11.544)。结论胰岛13细胞功能异常和(或)胰岛素抵抗是T2DM发病的基本环节,早期强化胰岛素治疗能获得血糖的有效控制,减少或延缓并发症的发生。 相似文献
103.
目的 了解肿瘤住院患者使用免疫调节药的现状,为临床合理用药提供参考。方法对2003~2005年免疫调节药应用情况运用药物使用频度(DDDs)、年均增率(AARG)等分析方法,进行统计分析。结果 免疫调节药销售金额年均增长率达106.69%。生物反应修饰剂销售金额占总金额的65.93%。生物反应修饰剂和增强免疫功能中成药用药频度相当。排序靠前的是金黄色葡萄球菌滤液注射液、参芪扶正注射液,用量上升最快的是香菇多糖注射液、胸腺素α1注射液。结论 免疫调节药是肿瘤放化疗必备用药,在肿瘤患者住院治疗中应用广泛。整体上该类药物的应用基本合理。疗效显著且作用广泛的药物成为临床首选。 相似文献
104.
Wen-Ni Chang Jen-Ning Tsai Bing-Hung Chen Huei-Sheng Huang Tzu-Fun Fu 《Drug metabolism and disposition》2007,35(11):2127-2137
Serine hydroxymethyltransferase (SHMT) provides activated one-carbon units required for the biosynthesis of nucleotides, protein, and methyl group by converting serine and tetrahydrofolate to glycine and N(5),N(10)-methylenetetrahydrofolate. It is postulated that SHMT activity is associated with the development of methotrexate resistance and the in vivo activity of SHMT is regulated by the binding of N(5)-CHO-THF, the rescue agent in high-dose methotrexate chemotherapy. The aim of this study is to advance our understanding of the folate-mediated one-carbon metabolism in zebrafish by characterizing zebrafish mitochondrial SHMT. The cDNA encoding zebrafish mitochondrial SHMT was cloned, overexpressed in Escherichia coli, and purified with a three-step purification protocol. Similarities in structural, physical, and kinetic properties were revealed between the recombinant zebrafish mitochondrial SHMT and its mammalian orthologs. Surprisingly, leucovorin significantly inhibits the aldol cleavage of serine catalyzed by zebrafish cytosolic SHMT but inhibits to a lesser extent the reaction catalyzed by the mitochondrial isozyme. This is, to our knowledge, the first report on zebrafish mitochondrial folate enzyme as well as the differential inhibition of leucovorin on these two SHMT isoforms. Western blot analysis revealed tissue-specific distribution with the highest enrichment present in liver for both cytosolic and mitochondrial SHMTs. Intracellular localization was confirmed by confocal microscopy for both mitochondrial and cytosolic SHMTs. Unexpectedly, the cytosolic isoform was observed in both nucleus and cytosol. Together with the previous report on zebrafish cytosolic SHMT, we suggest that zSHMTs can be used in in vitro assays for folate-related investigation and antifolate drug discovery. 相似文献
105.
106.
复杂主动脉病变的腔内血管外科治疗 总被引:3,自引:1,他引:2
目的 探讨复杂主动脉病变的腔内血管外科治疗方法。方法 对21例合并有内脏动脉缺血等复杂的主动脉病变,双球管定位下经锁骨上动脉到股动脉交换导丝以确保真腔内植入带膜支架,对真腔完全被假腔压闭的患者采取真腔内加压推进以通过导丝,用超长带膜支架来封堵大破口治疗夹层合并巨大假性动脉瘤形成,对夹层合并腹主动脉瘤患者采取血管腔内技术联合开腹手术等方法。结果 术后内漏3例,其中2例7 d后停止,1例漏血持续存在。3例主动脉创伤术后完全康复,余18例复杂主动脉夹层术后即时造影示瘘口已被完整覆盖,假腔无血漏入,内脏动脉等恢复真腔供血。18例中6例合并肠管缺血,3例合并肾动脉缺血,3例肠管缺血、肾动脉缺血,2例腹主动脉真腔完全被假腔压迫,以及2例合并下肢缺血术后均逐渐恢复,无脏器及肢体缺血坏死发生。2例合并腹主动脉瘤夹层行支架型人工血管封闭夹层破口后行开腹手术切除腹主动脉瘤、人工血管置换。16例随访5~36个月,平均22.3月,1例内漏持续存在,但假腔未继续加大,其余患者存活良好。结论 对复杂的主动脉病变的治疗,通过对腔内血管外科技术进行改进,并适当结合传统手术方法,使某些过去被认为不能够治疗的复杂主动脉病变可得以成功治疗。 相似文献
107.
G J Blauw P van Brummelen P C Chang P Vermeij P A van Zwieten 《Journal of cardiovascular pharmacology》1989,14(1):14-21
The influence of age on the regional arterial and venous effects of serotonin (5-HT) was investigated in 13 young (aged 22-31 years) and seven older (aged 50-69 years) healthy volunteers. Single-dose infusions of 5-HT (1, 10, and 80 ng/kg/min) and of the 5-HT2 receptor antagonist ritanserin (50, 150, and 500 ng/kg/min) were administered into the brachial artery. Subsequently, the relative arterial and venous effects of the highest dose of 5-HT were investigated. Forearm blood flow (FBF) and maximum venous outflow (MVO) were measured by venous occlusion plethysmography. Heart rate (HR) and intraarterial (i.a.) blood pressure were recorded semicontinuously. In both age groups, 5-HT induced an initial transient arterial dilation, followed by a persistent increase in FBF for the doses of 1 and 10 ng/kg/min and a relative small decrease in FBF for the highest dose. In both age groups, the highest dose of 5-HT induced a similar large reduction in MVO (p less than 0.05 for both). The reduction in MVO was attenuated by ritanserin (500 ng/kg/min, p less than 0.05 for both groups). In the younger subjects, this dose of ritanserin also unmasked an arterial dilator effect of the highest dose of 5-HT (p less than 0.05). The single infusions of ritanserin did not influence FBF significantly in either study group. No significant differences were observed between the age groups. These results show that in the forearm of healthy subjects arterial and venous vascular responses to 5-HT were not age-related. In the arterial vascular bed, 5-HT acted predominantly as a vasodilator; at high doses, mainly venous vasoconstriction was observed.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
108.
Wan-Ling Ho Tien-Wu Yang Wei-Chu Chi Hong-Jen Chang Li-Min Huang Mei-Hwei Chang 《台湾医志》2005,104(6):398-401
BACKGROUND AND PURPOSE: This study investigated the characteristics of intussusception in Taiwanese children of different age groups, including the incidence, length of hospitalization and hospital costs. METHODS: Children with a diagnosis of intussusception who were hospitalized from 1999 through 2001 were identified from a nationwide health insurance claims database. The incidence of intussusception was calculated by age, gender, and season. Length of hospitalization and hospital costs were also analyzed. RESULTS: A total of 6988 cases of intussusception were identified in Taiwan from 1999 to 2001. Among them, 4859 cases occurred in children below 15 years of age. The average incidence among children below age 15 years was 34.5 per 100,000, with a peak incidence of 118.8 per 100,000 observed among children younger than 24 months old. The highest incidence of intussusception in Taiwanese children occurred between 12 and 24 months of age. According to the data for patients below 15 years of age hospitalized for intussusception in year 2000, males were more likely to be affected than females (61.3% vs 38.7%). Intussusception-related hospitalizations were rare in infants in the first few months of life, increased in those 6 to 12 months old, and peaked among children 1 to 3 years old. Among the 952 patients with intussusception admitted to hospitals in 2000, 297 (31.2%) received surgery, incurring higher median medical costs (New Taiwan Dollars [NT dollars] 42,265 or US dollars 1234) and longer median hospital stay (6.2 days) than the 655 patients who did not require surgery (NT dollars 6290 or US dollars 185 for hospitalization of 2.4 days). CONCLUSIONS: The study found that the incidence of intussusception peaked in the second year of life in Taiwanese children. There was also a male predominance and lack of seasonal variation in incidence. 相似文献
109.
Tumor metastasis to the pancreas is a rare but recognized cause of acute pancreatitis. Autopsy series have reported a 24-40% of pancreatic involvement in small cell lung cancer. However, only a very few cases of tumor-induced acute pancreatitis have been described. Budd-Chiari syndrome complicating lung cancer is a rarely reported condition. We report a 68-year-old woman with extensive small cell lung cancer with the unusual initial presentation of both acute pancreatitis and acute Budd-Chiari syndrome. This patient suffered from progressive epigastralgia for 3 weeks. Severe epigastralgia with radiation to back and progressive jaundice developed 2 days prior to admission. After admission, the liver enlarged rapidly and the ascites increased markedly. Chest roentgenogram showed a mass lesion over the left lower lung field. Poorly differentiated carcinoma cells were found in ascites and bone marrow. The patient died on the ninth day of hospitalization before chemotherapy was initiated. Prompt diagnosis of extensive-stage small cell lung cancer may allow early chemotherapy treatment which favorably influences recovery when the pancreatitis is mild. Although prolonged survival might have been expected had this patient recovered from pancreatitis and received chemotherapy, diagnosis was delayed due to difficulty in immunohistochemical diagnosis of the tumor and the unusual clinical presentation. The use of stains employing antibodies against neurofilament and neuron-specific enolase cell antigens is important for early diagnosis of poorly differentiated metastatic tumor cells. 相似文献
110.
邹清如 《中华现代妇产科学杂志》2005,2(9):789-790
目的探讨第一产程胎心监护异常的相关因素,提示处理措施。方法2004年1月1日。12月31日对我院226例第一产程胎心监护异常的相关因素进行回顾性分析。结果第一产程胎心监护异常为综合因素所致,胎儿高危因素为91.59%,母体高危因素为65.49%,产程处理因素为42.92%。结论第一产程胎心监护异常主要与胎儿因素、母体因素有关,提高产前检查质量、加强产程监护、正确选择分娩方式极为重要。 相似文献